A Randomized Trial–Decreased 90-Day Surgical Site Complication Rates with ciNPT after Revision Knee Arthroplasty
Surgical complications are reported in up to 10% of hip and knee arthroplasties. The incidence of postoperative surgical complications is influenced by co-morbidities, interoperative risk factors and duration and complexity of surgery. Join Dr. Carlos Higuera, Primary Investigator on a randomized control trial (RCT) that demonstrates significantly lower 90-day Surgical Site Complication (SSC) rates using ciNPT vs. standard of care.
Carlos Higuera, MD
Center Director Orthopaedics and Rheumatology
Chairman, Levitetz Department of Orthopedic Surgery Cleveland Clinic Adult Reconstruction Center
Carlos Higuera-Rueda is currently a staff surgeon at Cleveland Clinic Florida, where he divides his time between leadership, research and patient care. He is the Chairman of the Levitetz Department of Orthopaedic Surgery at Cleveland Clinic Florida and Director of the Orthopaedic and Rheumatology Center. Dr. Higuera completed his residency at Cleveland Clinic and a clinical fellowship at Thomas Jefferson University Hospital.
Dr. Higuera specializes in hip and knee arthroplasty surgery. He is interested in complex revision procedures including infections. His research interest is mainly in periprosthetic joint infections including diagnostic tools, patient optimization and overall outcomes after arthroplasty. He is currently working on developing new technologies to diagnose and treat such infections. He is the president of the Musculoskeletal Infection Society.